Cargando…

Adeno-Associated Virus Mediated Gene Therapy for Corneal Diseases

According to the World Health Organization, corneal diseases are the fourth leading cause of blindness worldwide accounting for 5.1% of all ocular deficiencies. Current therapies for corneal diseases, which include eye drops, oral medications, corrective surgeries, and corneal transplantation are la...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bastola, Prabhakar, Song, Liujiang, Gilger, Brian C., Hirsch, Matthew L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464341/ https://www.ncbi.nlm.nih.gov/pubmed/32823625 http://dx.doi.org/10.3390/pharmaceutics12080767

Ejemplares similares

Harnessing the Natural Biology of Adeno-Associated Virus to Enhance the Efficacy of Cancer Gene Therapy
por: Bower, Jacquelyn J., et al.
Publicado: (2021)

Therapeutic Applications of Adeno-Associated Virus (AAV) Gene Transfer of HLA-G in the Eye
por: Gilger, Brian C., et al.
Publicado: (2022)

Ocular Tolerability and Immune Response to Corneal Intrastromal AAV-IDUA Gene Therapy in New Zealand White Rabbits
por: Song, Liujiang, et al.
Publicado: (2020)

Inhibition of experimental autoimmune uveitis by intravitreal AAV-Equine-IL10 gene therapy
por: Crabtree, Elizabeth, et al.
Publicado: (2022)

A Fixed-Depth Microneedle Enhances Reproducibility and Safety for Corneal Gene Therapy
por: Gilger, Brian C., et al.
Publicado: (2020)

Different tropism of adenoviruses and adeno-associated viruses to corneal cells: implications for corneal gene therapy
por: Liu, J., et al.
Publicado: (2008)

AAV Gene Therapy for MPS1-associated Corneal Blindness
por: Vance, Melisa, et al.
Publicado: (2016)

Adeno-Associated Virus Gene Therapy for Liver Disease
por: Kattenhorn, Lisa M., et al.
Publicado: (2016)

AAV-mediated expression of HLA-G1/5 reduces severity of experimental autoimmune uveitis
por: Crabtree, Elizabeth, et al.
Publicado: (2019)

Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
por: Naso, Michael F., et al.
Publicado: (2017)

Targeted Decorin Gene Therapy Delivered with Adeno-Associated Virus Effectively Retards Corneal Neovascularization In Vivo
por: Mohan, Rajiv R., et al.
Publicado: (2011)

Characteristics and advantages of adeno-associated virus vector-mediated gene therapy for neurodegenerative diseases
por: Qu, Yuan, et al.
Publicado: (2019)

My Pathway to Adeno-Associated Virus and Adeno-Associated Virus Gene Therapy: A Personal Perspective
por: Carter, Barrie J.
Publicado: (2020)

Adeno-Associated Virus-Based Gene Therapy for CNS Diseases
por: Hocquemiller, Michaël, et al.
Publicado: (2016)

Emerging therapeutic potential of adeno-associated virus-mediated gene therapy in liver fibrosis
por: Bu, Fang-tian, et al.
Publicado: (2022)

Optimization of the Capsid of Recombinant Adeno-Associated Virus 2 (AAV2) Vectors: The Final Threshold?
por: Aslanidi, George V., et al.
Publicado: (2013)

A survey of ex vivo/in vitro transduction efficiency of mammalian primary cells and cell lines with Nine natural adeno-associated virus (AAV1-9) and one engineered adeno-associated virus serotype
por: Ellis, Brian L, et al.
Publicado: (2013)

Enhancement of Adeno-Associated Virus-Mediated Gene Therapy Using Hydroxychloroquine in Murine and Human Tissues
por: Chandler, Laurel C., et al.
Publicado: (2019)

Enhancement of Adeno-Associated Virus-Mediated Gene Therapy Using Hydroxychloroquine in Murine and Human Tissues
por: Chandler, Laurel C., et al.
Publicado: (2023)

Adeno‐associated virus (AAV)-based gene therapy for glioblastoma
por: Xu, Xin, et al.
Publicado: (2021)

Routes of administration for adeno-associated viruses carrying gene therapies for brain diseases
por: Zhou, Kai, et al.
Publicado: (2022)

Adeno‐associated virus‐vectored erythropoietin gene therapy for anemia in cats with chronic kidney disease
por: Vaden, Shelly L., et al.
Publicado: (2023)

Adeno-associated virus-mediated gene therapy in a patient with Canavan disease using dual routes of administration and immune modulation
por: Corti, Manuela, et al.
Publicado: (2023)

Evaluation of Cellular Immune Response to Adeno-Associated Virus-Based Gene Therapy
por: Gorovits, Boris, et al.
Publicado: (2023)

Adeno-Associated Virus (AAV) - Based Gene Therapies for Retinal Diseases: Where are We?
por: Ail, Divya, et al.
Publicado: (2023)

The state of the art of adeno-associated virus-based vectors in gene therapy
por: Coura, Renata dos Santos, et al.
Publicado: (2007)

Adeno-Associated Virus (AAV)-Mediated Gene Therapy for Duchenne Muscular Dystrophy: The Issue of Transgene Persistence
por: Manini, Arianna, et al.
Publicado: (2022)

LBSUN178 Teniposide Improves Adeno-associated Virus-mediated Insulin Gene Therapy In Diabetic Mice.
por: Akcan, Tugce, et al.
Publicado: (2022)

Adeno-associated virus vector-mediated gene therapy for the treatment of ovarian cancer: a literature review
por: Zhu, Jiaojiao, et al.
Publicado: (2022)

Self-Complementary Adeno-Associated Virus Vectors Improve Transduction Efficiency of Corneal Endothelial Cells
por: Gruenert, Anja K., et al.
Publicado: (2016)

Effect of synovial fluid on adeno-associated virus mediated gene transfer to chondrocytes
por: Cottard, V, et al.
Publicado: (2003)

Adeno-Associated Virus Vector Mediated Delivery of the HBV Genome Induces Chronic Hepatitis B Virus Infection and Liver Fibrosis in Mice
por: Ye, Lei, et al.
Publicado: (2015)

Adeno-associated virus receptor complexes and implications for adeno-associated virus immune neutralization
por: Large, Edward E., et al.
Publicado: (2023)

Efficacy of Adeno-Associated Virus Serotype 9-Mediated Gene Therapy for AB-Variant GM2 Gangliosidosis
por: Vyas, Meera, et al.
Publicado: (2023)

Syndecan-4 Mediates the Cellular Entry of Adeno-Associated Virus 9
por: Hudák, Anett, et al.
Publicado: (2023)

Correction: The state of the art of adeno-associated virus-based vectors in gene therapy
por: dos Santos Coura, Renata, et al.
Publicado: (2010)

Recombinant adeno-associated virus 8 vector in gene therapy: Opportunities and challenges
por: Zhao, Liyuan, et al.
Publicado: (2023)

Modulation of the liver immune microenvironment by the adeno-associated virus serotype 8 gene therapy vector
por: Carestia, Agostina, et al.
Publicado: (2020)

Chimeric Adeno-Associated Virus-Mediated Cardiovascular Reprogramming for Ischemic Heart Disease
por: Yoo, So Young, et al.
Publicado: (2018)

The Role of the Adeno-Associated Virus Capsid in Gene Transfer
por: Van Vliet, Kim M., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_1k5g9rlp44o4lla3un97jdl61j